The Architect HIV Ag/Ab Combo has excellent performance for HIV screening; however, the false-positive rate (FPR) was high in low HIV prevalence setting.
| BACKG ROU N D
HIV/AIDS is a serious public health issue. Data from World Health Organization (WHO) have shown that people living with HIV (PLWH) were more than 35 million and 940 000 people died from HIV-related causes globally in 2017. 1 Since the HIV/AIDS was first reported in Beijing and Zhejiang Province in 1985, [2] [3] [4] the spread rate of HIV in China is alarming. Quite a few prevention policies and tremendous efforts, such as ban on imported blood products since 1985, 3 blood donors must be tested for HIV since 1995, methadone maintenance treatment program and four free one care, [2] [3] [4] [5] [6] have been made and performed for HIV/AIDS transmission in China. However, the HIV/AIDS epidemic in China is still not controlled. The registered PLWH in mainland China have increased from 664 751 in 2016 to 758 610 in 2017 and 810 910 at the end of June 2018, 7 although HIV prevalence remained rather low at an estimation of 0.06%. 8 The ARCHITECT HIV Ag/Ab Combo, which based on a chemiluminescent immunoassay with the ability to simultaneously detect p24 antigen and HIV-1/2 antibodies, has shortened the window period by around 1 week compared to the third-generation assay [9] [10] [11] and has a broader dynamic readout range. However, the rate of false positives (FP) by the fourth-generation assay was high in situations of low HIV prevalence. [12] [13] [14] The present study was carried out to analyze the influence of s/co ratios by Architect HIV Ag/Ab Combo with the results of supplemental tests and explore the optimal cutoff value to predict HIV infection. 
| ME THODS

| Study population
| Two-step HIV diagnostic algorithm
The nucleic acid and p24 antigen tests were not applied at Xi'an CDC; meanwhile, low HIV prevalence remained in China and positive predictive value of the fourth-generation assay was poor. [15] [16] [17] [18] Considering that Western blotting (WB) is a confirmatory test, a WB-negative result is often regarded as exclusion of HIV infection by the patient and clinician in China. The incorrect understand and treatment may lead to serious consequences for the early infections.
Since January 16, 2017, a new delivery protocol of blood samples that only reactive to HIV-1/2 Ab subjects should be conducted and WB has been developed by Xi'an CDC.
Based on this, a two-step HIV diagnostic algorithm is currently used at our hospital. The first step, a fourth-generation kit, Architect HIV Ag/Ab Combo (Abbott Diagnostics, Abbott Park, IL), which allows for identification of acute infection and importantly reduces the antibodyfree "window" period, is used as the HIV-1/2 initially screening test.
The second step, a third-generation EIA kit, XinChuang HIV-1/2 Ab (InTec, INC, XiaMen, FuJian, China), and a confirmatory test (WB) are used as the supplemental tests for the initially screening reactive cases.
For the third-and fourth-generation kits, the s/co ≥1 and s/co <1 were defined as reactive and non-reactive (negative), respectively. 
HIV
| Western blotting
Western blotting (HIV1/2 BLOT 2.2; MP Biomedicals, Singapore) is conducted at the Xi'an CDC, with the separated HIV-1 gene product 
| Statistical analysis
Statistical analyses were conducted by SPSS13.0 (serial number 5026743; SPSS Inc, Chicago, IL), and WB positive was the standard for HIV infection diagnosis in the study. The continuous variables were expressed by mean, the Mann-Whitney U test was used between two groups, and multiple groups were performed using the one-way ANOVA test and Kruskal-Wallis test. The receiver operating characteristic curve (ROC) analysis was used to determine the optimal cutoff value for predicting true positives (TP). A P-value <0.05 (two-tailed) was considered as statistically significant.
| RE SULTS
| The results of two-step algorithm
During the study period, 219 out of 84 702 patients were repeatedly reactive by ARCHITECT HIV Ag/Ab Combo. Of these, 113 and 106 were reactive and non-reactive to HIV-1/2 Ab EIA, respectively.
Among the 113 HIV-1/2 Ab reactive cases, 11 were previously WB ratios of HIV Ag/Ab Combo in TP were significantly higher than that in FP (458.15 vs 3.11, P < 0.0001), 
| Analysis of Western blotting results
Among the 69 WB-positive cases, there were 15 kinds of WB patterns, 84.06% (58/69) cases presented with reactivity to more than or equal to seven antigens patterns, and the s/co ratios had a statistically significant association with the band numbers, P = 0.0065.
According to the follow-up results of the WB-negative and indeter- 
| ROC analysis
With the exclusions of certain cases, that is, rejecting WB test (n = 25), unsuitable WB test (n = 1), and lost to follow-up (n = 1), a total of 84 675 cases were included with a 0.0992% (84/84 675) of HIV prevalence. ROC analysis showed that the optimal cutoff value based on the highest sum of sensitivity (100%) and specificity (100%) was estimated to be 24.44. When the s/co ratios of 1, 9.64 and 17.42
were used as the cutoff value for HIV infection diagnosis, it can achieve 100% of sensitivity and 99.87%-99.96% of specificity, and false-positive rate (FPR) decreased from 56.25% to 3.45%. When the cutoff was revised to 31.90 and 38.66, it can achieve 100% of specificity and provide no false-positive results; however, the sensitivity was decreased to 98.81% and 97.62%, respectively, Table 3 . The Architect HIV Ag/Ab Combo has proven to be highly reliable for HIV screening; however, the frequency of false-positive results was high in low HIV prevalence setting. [12] [13] [14] [18] [19] [20] In our study population, Architect HIV Ag/Ab Combo can provide high sensitivity (100%) and specificity (99.87%) with a with a 0.0992% of HIV prevalence. However, high FPR (56.25%) was observed, which was similar with other reports in China (39.5%) 18 and Korea (69.8%). 12 The mean s/co ratios in TP were significantly higher than that in FP (458.15 vs 3.11). In WB positives, with the increase in the number of bands, the s/co ratios increased significantly. The optimal cutoff value of Architect HIV Ag/Ab Combo in the study, which can provide the highest sum of sensitivity (100%) and 
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